Sodium-glucose co-transporter-2 inhibitors and the risk of venous thromboembolism: A nationwide population-based study and meta-analysis.
Diabetes Metab Res Rev
; 40(2): e3739, 2024 Feb.
Article
in En
| MEDLINE
| ID: mdl-37862117
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Symporters
/
Diabetes Mellitus, Type 2
/
Venous Thromboembolism
/
Dipeptidyl-Peptidase IV Inhibitors
/
Sodium-Glucose Transporter 2 Inhibitors
Type of study:
Systematic_reviews
Limits:
Humans
Language:
En
Year:
2024
Type:
Article